Sirolimus and Mycophenolate Mofetil in Preventing GVHD in Patients With Hematologic Malignancies Undergoing HSCT
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Myelofibrosis
Related studies linked through entity extraction aliases.
Cell Cycle Regulatory Gene Study in Patients With Myeloproliferative Disorders
- Status
- WITHDRAWN
- Phase
- N/A
URMC Related Haplo-identical Donor BMT
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate the Efficacy and Safety of Vismodegib in Combination With Ruxolitinib for the Treatment of Intermediate- or High-Risk Myelofibrosis (MF)
- Status
- COMPLETED
- Phase
- PHASE1
Reduced Intensity Conditioning Transplant Using Haploidentical Donors
- Status
- COMPLETED
- Phase
- PHASE2
Pacritinib in Combination With Low Dose Decitabine in Intermediate-High Risk Myelofibrosis or Myeloproliferative Neoplasm (MPN)/Myelodysplastic Syndrome (MDS)
- Status
- WITHDRAWN
- Phase
- PHASE1
Shorter Course Tacro After NMA, Related Donor PBSCT With High-dose Posttransplant Cy for Hard-to-Engraft Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Alisertib in Treating Patients With Myelofibrosis or Relapsed or Refractory Acute Megakaryoblastic Leukemia
- Status
- UNKNOWN
- Phase
- NA
Hu8F4 in Treating Patients With Advanced Hematologic Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Multi-antigen CMV-MVA Triplex Vaccine in Reducing CMV Complications in Patients Previously Infected With CMV and Undergoing Donor Hematopoietic Cell Transplant
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
TGR-1202 + Ruxolitinib PMF PPV-MF PET-MF MDS/MPN Polycythemia Vera Resistant to Hydroxyurea
- Status
- COMPLETED
- Phase
- PHASE1
Ruxolitinib in Combination With Autotransplant
- Status
- WITHDRAWN
- Phase
- NA
A Phase 1/2 Study To Evaluate ASN002 In Relapsed/Refractory Lymphoma And Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Idelalisib in Adults Receiving Ruxolitinib as Therapy for Primary, Post-Polycythemia Vera, or Post-Essential Thrombocythemia Myelofibrosis With Progressive or Relapsed Disease
- Status
- TERMINATED
- Phase
- PHASE1
iCare for Cancer Patients
- Status
- TERMINATED
- Phase
- NA
Study to Evaluate Activity of 2 Dose Levels of Imetelstat in Participants With Intermediate-2 or High-Risk Myelofibrosis (MF) Previously Treated With Janus Kinase (JAK) Inhibitor
- Status
- COMPLETED
- Phase
- PHASE2
Vaccine Therapy in Reducing the Frequency of Cytomegalovirus Events in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE2
Study of the Safety of PIM447 in Combination With Ruxolitinib (INC424) and LEE011 in Patients With Myelofibrosis
- Status
- COMPLETED
- Phase
- PHASE1
Tagraxofusp (SL-401) in Participants With Chronic Myelomonocytic Leukemia (CMML) and Myelofibrosis (MF)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Intra-Osseous Co-Transplant of UCB and hMSC
- Status
- COMPLETED
- Phase
- EARLY_PHASE1